2667 — Beijing Tong Ren Tang Healthcare Investment Income Statement
0.000.00%
- HK$828.72m
- HK$1.11bn
- CNY1.18bn
Annual income statement for Beijing Tong Ren Tang Healthcare Investment, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final |
| Revenue | |||
| Total Revenue | 911 | 1,153 | 1,175 |
| Cost of Revenue | |||
| Gross Profit | 143 | 217 | 222 |
| Selling / General / Administrative Expenses | |||
| Depreciation and Amortization | |||
| Operating Interest Expense / Income | |||
| Unusual Expense / Income | |||
| Other Operating Expenses | |||
| Total Operating Expenses | 898 | 1,078 | 1,100 |
| Operating Profit | 13.2 | 74.7 | 75.5 |
| Total Net Non Operating Interest Income / Expense | |||
| Total Net Non Operating Interest Income / Expense | |||
| Other Net Non Operating Costs | |||
| Net Income Before Taxes | 6.21 | 65.5 | 61.4 |
| Provision for Income Taxes | |||
| Net Income After Taxes | -9.23 | 42.6 | 46.2 |
| Minority Interest | |||
| Net Income Before Extraordinary Items | |||
| Net Income | -16.3 | 22.3 | 36.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||
| Income Available to Common Shareholders Including Extraordinary Items | |||
| Diluted Net Income | -16.3 | 22.3 | 36.9 |
| Diluted Weighted Average Shares | |||
| Basic EPS Including Extraordinary Items | |||
| Diluted EPS Including Extraordinary Items | |||
| Diluted EPS Excluding Extraordinary Items | |||
| Normalised Income Before Taxes | |||
| Normalised Income After Taxes | |||
| Normalised Income Available to Common Shareholders | |||
| Diluted Normalised EPS | -0.037 | 0.055 | 0.076 |